Tauopathy is more tightly associated with cognitive decline in AD, and study and modeling of FTDP-17 caused by mutations in tau reveals a tight link between tau aggregation and neurotoxicity, but we still lack detailed mechanistic insights into how tau dysfunction and aggregation damages brain cells [238–242]. The gene discussed is MAPT; the disease is Alzheimer disease.